Can a texting buddy help new moms battling opioid addiction?

NCT ID NCT06969261

Recruiting now Symptom relief Sponsor: University of Pennsylvania Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jul 29, 2026 · Updated 3 times

Summary

This study is adapting a friendly text-message chatbot called Penny to support pregnant and postpartum women who are recovering from opioid use disorder. The chatbot sends helpful messages and allows two-way conversations to reduce loneliness and keep women engaged in their care. Researchers will test it with 20 women to see if it's acceptable, easy to use, and satisfying.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Penny COPILOT chatbot (behavioral intervention via SMS)
What this could lead to: If successful, this chatbot could offer a low-cost, scalable way to support perinatal women with opioid use disorder, reducing loneliness and relapse risk.
What could go wrong: This is a very small pilot study (20 participants) focused on feasibility, not effectiveness. The chatbot may not work for everyone, and results may not apply to broader populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OPIOID-USE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

opiate dependence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OPIOID-USE DISORDER PERINATAL OPIOID USE DISORDER

Contacts and locations

Locations

Hospital of the University of Pennsylvania (HUP)
RECRUITING

Philadelphia, Pennsylvania, 19072, United States
University of Pennsylvania
NOT_YET_RECRUITING

Philadelphia, Pennsylvania, 19104-3309, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.